Literature DB >> 26303012

Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study.

Katherina P Farr1, Jesper F Kallehauge2, Ditte S Møller2, Azza A Khalil3, Stine Kramer4, Henrik Bluhme4, Anni Morsing4, Cai Grau3.   

Abstract

BACKGROUND AND
PURPOSE: To compare functional and standard dose-volume parameters as predictors of postradiation pulmonary toxicity in lung cancer patients undergoing curative chemo-radiotherapy (RT) studied prospectively.
MATERIAL AND METHODS: A total of 58 patients treated with Intensity Modulated RT (60-66Gy) were analysed. Standard dose-volume parameters were extracted from treatment planning computed tomography (CT) scans. Corresponding functional dose-volume parameters were calculated from perfusion single-photon emission computed tomography (SPECT). Primary end-point was radiation pneumonitis (RP) grade 2-5.
RESULTS: Functional mean lung dose (MLD) and lung volumes receiving 5, 10, 20 and 30Gy (V5-V30, respectively) revealed high correlation with corresponding standard parameters (r>0.8). Standard MLD, V20 and V30 were significantly higher in patients with RP (p=0.01). All functional parameters were significantly higher in the RP patients (p<0.03). In multivariate analysis functional parameters produced superior risk estimates, while all standard parameters, except V30, were not related to the risk of RP. Area under the curve (AUC) for functional metrics generally exceeded the AUC for corresponding standard parameters, but they were not significantly different from each other.
CONCLUSION: SPECT-based functional parameters were better to predict the risk of RP compared to standard CT-based dose-volume parameters. Functional parameters may be useful to guide radiotherapy planning in order to reduce the risk of radiation-induced toxicity.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Functional imaging; IMRT; Non-small-cell lung cancer; Radiation pneumonitis; Radiation-induced lung toxicity; SPECT/CT

Mesh:

Substances:

Year:  2015        PMID: 26303012     DOI: 10.1016/j.radonc.2015.08.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  22 in total

1.  Treatment planning based on lung functional avoidance is not ready for clinical deployment.

Authors:  Amit Sawant; Tokihiro Yamamoto; Jing Cai
Journal:  Med Phys       Date:  2018-04-14       Impact factor: 4.071

2.  Image-based lung functional radiotherapy planning for non-small cell lung cancer.

Authors:  Faegheh S Mounessi; Jörg Eckardt; Arne Holstein; Santiago Ewig; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2019-10-02       Impact factor: 3.621

3.  Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.

Authors:  Gurleen Dhami; Jing Zeng; Hubert J Vesselle; Paul E Kinahan; Robert S Miyaoka; Shilpen A Patel; Ramesh Rengan; Stephen R Bowen
Journal:  Strahlenther Onkol       Date:  2017-03-02       Impact factor: 3.621

4.  Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR.

Authors:  Narges Kazemzadeh; Arezoo Modiri; Santanu Samanta; Yulong Yan; Ross Bland; Timothy Rozario; Henky Wibowo; Puneeth Iyengar; Chul Ahn; Robert Timmerman; Amit Sawant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-02       Impact factor: 7.038

5.  Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.

Authors:  Tokihiro Yamamoto; Sven Kabus; Matthieu Bal; Karl Bzdusek; Paul J Keall; Cari Wright; Stanley H Benedict; Megan E Daly
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-04       Impact factor: 7.038

6.  Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.

Authors:  Daniel Rocky Owen; Phillip S Boonstra; Benjamin L Viglianti; James M Balter; Matthew J Schipper; William C Jackson; Issam El Naqa; Shruti Jolly; Randall K Ten Haken; Feng-Ming Spring Kong; Martha M Matuszak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

7.  Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.

Authors:  Mohammed Alharbi; Stefan Janssen; Heiko Golpon; Michael Bremer; Christoph Henkenberens
Journal:  Radiat Oncol       Date:  2017-11-02       Impact factor: 3.481

8.  Hyperpolarized 129Xe Magnetic Resonance Imaging for Functional Avoidance Treatment Planning in Thoracic Radiation Therapy: A Comparison of Ventilation- and Gas Exchange-Guided Treatment Plans.

Authors:  Leith J Rankine; Ziyi Wang; Chris R Kelsey; Elianna Bier; Bastiaan Driehuys; Lawrence B Marks; Shiva K Das
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-07-13       Impact factor: 7.038

9.  Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients.

Authors:  Lehui Du; Wei Yu; Xiangkun Dai; Nana Zhao; Xiang Huang; Fang Tong; Fang Liu; Yurong Huang; Zhongjian Ju; Wei Yang; Xiaohu Cong; Chuanbin Xie; Xiaoliang Liu; Lanqing Liang; Yanan Han; Baolin Qu
Journal:  Oncotarget       Date:  2017-12-05

Review 10.  The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.

Authors:  Hossein Jadvar
Journal:  Diagnostics (Basel)       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.